business and economics

With a new method for modifying antibodies, drugs are developped showing more stability and, thus, having fewer side-effects. At the time Spycher, a postdoctoral radiopharmaceutical researcher at the Paul Scherrer Institute PSI, was concerned with the question of how active agents could be bound to antibodies more efficiently.